Australia's public equity markets have lost another potential listing as supermarket giant Coles moves to acquire Greencross, the pet-health business owned by TPG Capital.
The deal effectively removes a high-profile candidate from the already anemic initial public offering pipeline, leaving investors with fewer opportunities to access new equity supply in the region.
The acquisition underscores the persistent weakness in the Australian IPO market, which entered 2026 with high hopes centered on Firmus, the private equity firm widely expected to deliver the largest listing in the country's history.
While advisers for Firmus are reportedly still planning its float, the loss of Greencross highlights the fragility of the current pipeline.
With major candidates being absorbed by existing public entities or remaining private, the scarcity of new listings continues to weigh on market breadth.
Investors and analysts have expressed disappointment over the direction of the Greencross deal, viewing it as a missed opportunity to diversify the ASX's sector composition.